Hantao Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hantao Luo has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Leping Sun
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology 510006 , Guangzhou
2 shared publications - Tingjian Chen
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China
2 shared publications - Binliang Zhang
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology , Guangzhou 510006
1 shared publication Chenghe Xiong
Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences , Shenzhen 518055
1 shared publicationFangkai Ye
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology 510006 , Guangzhou
1 shared publicationGan Zhu
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology , Guangzhou 510006
1 shared publication
Latest Publications
- Open Access
- 5 January 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (1)
Recognition of unnatural base pairs by a eukaryotic DNA polymerase enables universal sequencing of an expanded genetic alphabet
The expansion of the genetic alphabet through the development of unnatural base pairs (UBPs) has the potential to revolutionize synthetic biology and biotechnology. However, the replication of the UBPs by eukaryotic DNA polymerases is largely unexplored and the sequencing of the UBPs remains challenging. Herein, we explored and demonstrated the activity of human DNA polymerase β (Pol β) for the efficient and specific synthesis and extension of a panel of representative UBPs, including dNaM–dTPT3, dCNMO–dTPT3, and their functionalized derivatives. Based on this, we established a method for the sequencing of DNAs containing different unnatural bases, involving stalled primer extension mediated by Pol β, selective conversion of an unnatural nucleotide into two different natural ones in parallel and further primer extension mediated by Taq DNA polymerase, and Sanger or deep sequencing of the produced natural DNAs to locate the unnatural bases. The precision, universality, and potential for high-throughput applications of this method were demonstrated by the successful sequencing of various DNAs containing one or multiple of different unnatural bases. This work suggests the possibility of integrating the UBPs into the eukaryotic DNA replication systems and provides a technical foundation for the robust sequencing of DNAs with an expanded genetic alphabet.
- 5 January 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (1)
Open AccessRecognition of unnatural base pairs by a eukaryotic DNA polymerase enables universal sequencing of an expanded genetic alphabet
The expansion of the genetic alphabet through the development of unnatural base pairs (UBPs) has the potential to revolutionize synthetic biology and biotechnology. However, the replication of the UBPs by eukaryotic DNA polymerases is largely unexplored and the sequencing of the UBPs remains challenging. Herein, we explored and demonstrated the activity of human DNA polymerase β (Pol β) for the efficient and specific synthesis and extension of a panel of representative UBPs, including dNaM–dTPT3, dCNMO–dTPT3, and their functionalized derivatives. Based on this, we established a method for the sequencing of DNAs containing different unnatural bases, involving stalled primer extension mediated by Pol β, selective conversion of an unnatural nucleotide into two different natural ones in parallel and further primer extension mediated by Taq DNA polymerase, and Sanger or deep sequencing of the produced natural DNAs to locate the unnatural bases. The precision, universality, and potential for high-throughput applications of this method were demonstrated by the successful sequencing of various DNAs containing one or multiple of different unnatural bases. This work suggests the possibility of integrating the UBPs into the eukaryotic DNA replication systems and provides a technical foundation for the robust sequencing of DNAs with an expanded genetic alphabet.
- Open Access
- 20 June 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (12)
A solid-phase enzymatic synthesis platform for the facile production of 2′-fluoroarabinonucleic acid (FANA) and chimeric XNA oligonucleotides using an evolved XNA polymerase
Xenobiotic nucleic acids (XNAs) significantly expand the range of genetic polymers and serve as promising alternatives to DNA and RNA for numerous biological applications. However, the extensive exploration and application of XNAs are limited by low sustainability and yields in solid-phase oligonucleotide synthesis, as well as by the unavailability of efficient XNA polymerases for polymerase-mediated XNA production. To address the limitations in XNA production, we developed a solid-phase enzymatic XNA oligonucleotide synthesis platform using a laboratory-evolved XNA polymerase, SFM5-7, which exhibits excellent activity for synthesizing DNA, RNA, 2′-fluoroarabinonucleic acid (FANA), and other 2′-modified XNA oligonucleotides. This platform employs ribonucleotide insertion and alkaline cleavage of the oligonucleotide product before and after SFM5-7-mediated XNA synthesis, enabling recycled XNA synthesis through the reuse of a bead-immobilized self-priming hairpin DNA template. The platform’s potential and versatility are demonstrated by the production of FANA, 2′-modified RNAs, chimeric XNAs, 5′-end-labeled FANA, and an active FANAzyme. This platform should facilitate the customized production of functional XNAs with programmable modifications, accelerating their applications in biotechnology and biomedicine.
- 20 June 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (12)
Open AccessA solid-phase enzymatic synthesis platform for the facile production of 2′-fluoroarabinonucleic acid (FANA) and chimeric XNA oligonucleotides using an evolved XNA polymerase
Xenobiotic nucleic acids (XNAs) significantly expand the range of genetic polymers and serve as promising alternatives to DNA and RNA for numerous biological applications. However, the extensive exploration and application of XNAs are limited by low sustainability and yields in solid-phase oligonucleotide synthesis, as well as by the unavailability of efficient XNA polymerases for polymerase-mediated XNA production. To address the limitations in XNA production, we developed a solid-phase enzymatic XNA oligonucleotide synthesis platform using a laboratory-evolved XNA polymerase, SFM5-7, which exhibits excellent activity for synthesizing DNA, RNA, 2′-fluoroarabinonucleic acid (FANA), and other 2′-modified XNA oligonucleotides. This platform employs ribonucleotide insertion and alkaline cleavage of the oligonucleotide product before and after SFM5-7-mediated XNA synthesis, enabling recycled XNA synthesis through the reuse of a bead-immobilized self-priming hairpin DNA template. The platform’s potential and versatility are demonstrated by the production of FANA, 2′-modified RNAs, chimeric XNAs, 5′-end-labeled FANA, and an active FANAzyme. This platform should facilitate the customized production of functional XNAs with programmable modifications, accelerating their applications in biotechnology and biomedicine.